A Randomised Control Trial of Fluorescence Guided Sarcoma Surgery Versus the Standard of Care
A Randomised Control Trial of Fluorescence Guided Sarcoma Surgery Versus the Standard of Care
Recruitment to the SarcoSIGHT trial was paused on 14th November 2024 and will remain paused to recruitment while certain MHRA requirements are being addressed. We are continuing to follow-up existing trial patients and to collect information from them. We will provide an update on the status of the trial as soon as it becomes available.
NIHR Programme
The trial is funded by the National Institute for Health Research
Newcastle University
The trial is managed by the Newcastle Clinical Trials Unit (NCTU) - a UKCRC Registered Clinical Trials Unit
NuTH
The trial sponsor is Newcastle upon Tyne Hospitals NHS Foundation Trust
